Position in ATYR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$35,195
-$101,189 QoQ
Shares Held
45,123
-74.1% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 109 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,076,655 across 360 Biotechnology names. ATYR ranks #290 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in ATYR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,195 | 45,123 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $136,384 | 174,182 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $246,119 | 341,359 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $1,503,691 | 296,586 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $716,014 | 237,091 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $577,053 | 159,407 | Shares | Sole | 2026-03-19 | |
| 2024-03-31 | $1,178,382 | 604,299 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $111,350 | 78,972 | Shares | Sole | 2026-03-24 | |
| No filing history on record for this holder in this stock. | ||||||